When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Fate Therapeutics (NASDAQ:FATE) is scheduled to announce Q3 earnings results on Thursday, November 5th, after market close.The consensus EPS Estimate is -$0.36 (+10.0% Y/Y) and the consensus Revenue Estimate is $7.49M (+208.2% Y/Y).Over the last 1 year, FATE has beaten EPS estimates 0% of the time and has beaten revenue estimates 75% of the time.Over the last 3 months, EPS estimates have seen 13 upward revisions and 0 downward. Revenue estimates have seen 6 upward revisions and 0 downward.